Background Whether the safety and efficacy of percutaneous transluminal angioplasty and stenting (PTAS) is significantly different from that of medical treatment alone for symptomatic intracranial ...

[28] The BMS plus DEB strategy had numerically higher 6 month in-stent late loss (0.64 vs 0.43 mm; p = 0.14) and binary restenosis (27.7 vs 14.6%; p = 0.12), although clinical safety end points ...

The paclitaxel-coated balloon catheter versus a paclitaxel-coated stent for the treatment of ISR (PEPCAD ISR II) study was a prospective, randomized, multicenter, two-arm Phase II pilot study ...

Carotid artery stenting (CAS) is an alternative treatment for patients with carotid artery stenosis who are not eligible for carotid endarterectomy. Dual antiplatelet therapy (DAPT) after CAS aims to ...